Search For "respiratory distress syndrome"
Rainbow Children's Hospital Saves Three-Year-Old in Extremely Rare Critica
Updated : 7 months, 3 weeks ago IST
Bengaluru (Karnataka) [India], September 6: In a complex case within paediatric critical care, physicians at Rainbow Children's Hospital, Bannerghatta Road, have treated successfully a three-year-old boy from Bengaluru who suffered from tuberous sclerosis, refractory seizures, alongside seve
Read More
Study finds how new type of cell therapy help ARDS patients
Updated : 2 years, 3 months ago IST
A novel form of cell therapy may help patients who are critically ill with acute respiratory distress syndrome (ARDS) brought on by severe COVID-19, according to a study.
Read More
New type of cell therapy shows promise for ARDS patients
Updated : 7 months, 3 weeks ago IST
A study suggested that a new type of cell therapy may improve the prognosis of patients critically unwell with acute respiratory distress syndrome (ARDS) caused by severe COVID-19.
Read More
A First for India: Rainbow Children's Hospital Saves Baby by Airlifting wi
Updated : 2 years, 6 months ago IST
Hyderabad (Telangana) [India], October 28: Rainbow Children's Hospital has displayed the highest degree of medical expertise and commitment by saving an 18-month-old baby boy from Goa who was suffering from severe Pneumonia and ARDS and was on the highest ventilatory support. Rainbow Childre
Read More
India's first case of surfactant therapy using salsa technique in a pre-te
Updated : 3 years, 3 months ago IST
Surfactant therapy has been the mainstay of treatment for preterm neonates with respiratory distress syndrome. Surfactant therapy is the delivery of a special liquid into the immature lungs of newly born premature babies suffering from breathing difficulty.
Read More
Cystic fibrosis drug could help treat pneumonia: Research
Updated : 3 years, 5 months ago IST
Pathogens such as SARS-CoV-2 and pneumococcus can cause severe pneumonia. If the airways then fill with fluid, the patient risks developing acute respiratory distress syndrome.
Read More
Research shows how a viral toxin may exacerbate severe COVID-19
Updated : 3 years, 5 months ago IST
A new study in the journal Nature Communications reveals how a viral toxin produced by the SARS-CoV-2 virus may contribute to severe COVID-19 infections. The study shows how a portion of the SARS-CoV-2 "spike" protein can damage cell barriers that line the inside of blood vessels within orga
Read More
Researchers find respiratory infections cause extreme stress to cells, org
Updated : 3 years, 8 months ago IST
Washington [US], September 5 (ANI): Many respiratory infections, such as influenza or COVID-19, cause extreme stress to cells and organs, resulting in acute respiratory distress syndrome (ARDS), which can finally lead to death in the elderly or fragile people.
Read More
Study: Stressed mitochondria help cells to withstand lung infections
Updated : 3 years, 8 months ago IST
Washington [US], August 31 (ANI): Many respiratory infections, such as influenza or COVID-19, cause severe stress to cells and organs, leading to acute respiratory distress syndrome (ARDS), which can eventually lead to mortality in elderly or vulnerable people.
Read More
FDA approves Direct Biologics to proceed with a Landmark Phase 3 Acute Res
Updated : 4 years, 1 month ago IST
Austin (Texas) [US], April 22 (ANI/PRNewswire): Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigatio
Read More
FDA grants Direct Biologics regenerative Medicine Advanced Therapy (RMAT)
Updated : 4 years, 1 month ago IST
Austin (Texas) [US], April 13 (ANI/PRNewswire): Direct Biologics, an innovative biotechnology company with a groundbreaking extracellular vesicle (EV) platform drug technology, announced that the U.S. Food and Drug Administration (FDA) has awarded their EV drug product ExoFlo with a Regenera
Read More
Direct Biologics reveals successful outcomes from EXIT COVID-19 Phase II C
Updated : 4 years, 1 month ago IST
Austin [Texas], April 6 (ANI/PRNewswire): Direct Biologics, a regenerative biotechnology company with a lifesaving mesenchymal stem cell (MSC) derived extracellular vesicle (EV) platform technology, announces topline results from its first-in-human, multicenter, Phase II double-blind, placeb
Read More